Showing 1 - 5 results of 5 for search 'Giacomo Allegrini', query time: 0.02s Refine Results
  1. 1
    A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study

    A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study by Valentina D. A. Corino, Marco Bologna, Giuseppina Calareso, Lisa Licitra, Mariagrazia Ghi, Gaetana Rinaldi, Francesco Caponigro, Franco Morelli, Mario Airoldi, Giacomo Allegrini, Alessandra Cassano, Daris Ferrari, Aurora Mirabile, Alicia Tosoni, Danilo Galizia, Marco Merlano, Andrea Sponghini, Gabriella Moretti, Luca Mainardi, Paolo Bossi

    Published 2021-05-01
    Get full text
    Article
  2. 2
    Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab

    Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab by Nerina Denaro, Lisa Licitra, Marco Merlano, Francesco Perri, Paolo Bossi, Cristina Gurizzan, Federica Perrone, Athanassios Argiris, Loris De Cecco, Stefano Cavalieri, Mara Serena Serafini, Federico Pistore, Deborah Lenoci, Silvana Canevari, Mario Airoldi, Maria Cossu Rocca, Primoz Strojan, Cvetka Grasic Kuhar, Andrea Vingiani, Maria Grazia Ghi, Alessandra Cassano, Giacomo Allegrini

    Published 2024-01-01
    Get full text
    Article
  3. 3
    TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

    TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group by Chiara Cremolini, Federica Marmorino, Fotios Loupakis, Gianluca Masi, Carlotta Antoniotti, Lisa Salvatore, Marta Schirripa, Luca Boni, Vittorina Zagonel, Sara Lonardi, Giuseppe Aprile, Emiliano Tamburini, Vincenzo Ricci, Monica Ronzoni, Filippo Pietrantonio, Chiara Valsuani, Gianluca Tomasello, Alessandro Passardi, Giacomo Allegrini, Samantha Di Donato, Daniele Santini, Alfredo Falcone, on behalf of all the investigators of the Gruppo Oncologico del Nord Ovest

    Published 2017-06-01
    Get full text
    Article
  4. 4
    Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression

    Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression by Marzia Del Re, Giovanna Irene Luculli, Iacopo Petrini, Andrea Sbrana, Vieri Scotti, Diego de Miguel Perez, Lorenzo Livi, Stefania Crucitta, Mauro Iannopollo, Francesca Mazzoni, Martina Ruglioni, Carmelo Tibaldi, Emanuela Olmetto, Irene Stasi, Editta Baldini, Giacomo Allegrini, Lorenzo Antonuzzo, Franco Morelli, Andrea Pierini, Nicola Panzeri, Stefano Fogli, Antonio Chella, Christian Rolfo, Romano Danesi

    Published 2024-03-01
    Get full text
    Article
  5. 5
    A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients

    A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients by Luigi Coltelli, Giacomo Allegrini, Paola Orlandi, Chiara Finale, Andrea Fontana, Luna Chiara Masini, Marco Scalese, Giada Arrighi, Maria Teresa Barletta, Ermelinda De Maio, Marta Banchi, Elisabetta Fini, Patrizia Guidi, Giada Frenzilli, Sara Donati, Simona Giovannelli, Lucia Tanganelli, Barbara Salvadori, Lorenzo Livi, Icro Meattini, Ilaria Pazzagli, Marco Di Lieto, Mirco Pistelli, Virginia Casadei, Antonella Ferro, Samanta Cupini, Francesca Orlandi, Damiana Francesca, Giulia Lorenzini, Leonardo Barellini, Alfredo Falcone, Alessandro Cosimi, Guido Bocci

    Published 2022-03-01
    Get full text
    Article

Search Tools: